Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis.

CONCLUSIONS: The activity of endocrine therapy in advanced EOC is worth considering and seems to support large properly designed randomized trials in the first treatment of hormone sensitive EOC.
PMID: 28705409 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - July 10, 2017 Category: Cancer & Oncology Authors: Paleari L, Gandini S, Provinciali N, Puntoni M, Colombo N, DeCensi A Tags: Gynecol Oncol Source Type: research